Zacks: Analysts Anticipate Corium International Inc (CORI) to Post -$0.33 EPS
Equities analysts predict that Corium International Inc (NASDAQ:CORI) will announce ($0.33) earnings per share for the current quarter, Zacks reports. Two analysts have issued estimates for Corium International’s earnings, with estimates ranging from ($0.36) to ($0.29). Corium International posted earnings of ($0.36) per share in the same quarter last year, which suggests a positive year over year growth rate of 8.3%. The company is scheduled to issue its next quarterly earnings results on Thursday, November 15th.
On average, analysts expect that Corium International will report full year earnings of ($1.53) per share for the current year, with EPS estimates ranging from ($1.56) to ($1.50). For the next financial year, analysts anticipate that the business will post earnings of ($1.42) per share, with EPS estimates ranging from ($1.73) to ($1.10). Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Corium International.
A number of brokerages recently commented on CORI. BidaskClub upgraded shares of Corium International from a “strong sell” rating to a “sell” rating in a research report on Tuesday, November 13th. Needham & Company LLC downgraded shares of Corium International from a “buy” rating to a “hold” rating in a research report on Monday, October 15th. HC Wainwright downgraded shares of Corium International from a “buy” rating to a “neutral” rating and set a $13.00 price objective for the company. in a research report on Monday, October 15th. ValuEngine upgraded shares of Corium International from a “buy” rating to a “strong-buy” rating in a research report on Friday, October 12th. Finally, Zacks Investment Research upgraded shares of Corium International from a “sell” rating to a “hold” rating in a research report on Tuesday, August 14th. One analyst has rated the stock with a sell rating, three have given a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. Corium International presently has an average rating of “Hold” and a consensus price target of $13.50.
A number of institutional investors have recently modified their holdings of CORI. SG Americas Securities LLC purchased a new position in Corium International in the third quarter valued at about $145,000. Man Group plc purchased a new position in Corium International in the third quarter valued at about $163,000. Engineers Gate Manager LP purchased a new position in Corium International in the second quarter valued at about $215,000. Alps Advisors Inc. purchased a new position in Corium International in the second quarter valued at about $420,000. Finally, Schwab Charles Investment Management Inc. increased its holdings in Corium International by 40.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 58,309 shares of the biopharmaceutical company’s stock valued at $468,000 after buying an additional 16,900 shares in the last quarter.
Shares of NASDAQ:CORI opened at $12.65 on Friday. The company has a debt-to-equity ratio of 2.83, a current ratio of 7.61 and a quick ratio of 7.47. The stock has a market capitalization of $458.56 million, a P/E ratio of -7.71 and a beta of 0.87. Corium International has a 52 week low of $7.17 and a 52 week high of $13.93.
Corium International Company Profile
Corium International, Inc, a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. It offers Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening.
Read More: Average Daily Trade Volume Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Corium International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corium International and related companies with MarketBeat.com's FREE daily email newsletter.